Literature DB >> 28103055

The discovery and development of the CRISPR system in applications in genome manipulation.

Veronica Lau1,1, James R Davie1,1.   

Abstract

The clustered regularly interspaced short palindromic repeat (CRISPR) associated 9 (Cas9) system is a microbial adaptive immune system that has been recently developed for genomic engineering. From the moment the CRISPR system was discovered in Escherichia coli, the drive to understand the mechanism prevailed, leading to rapid advancement in the knowledge and applications of the CRISPR system. With the ability to characterize and understand the function of the Cas9 endonuclease came the ability to adapt the CRISPR-Cas9 system for use in a variety of applications and disciplines ranging from agriculture to biomedicine. This review will provide a brief overview of the discovery and development of the CRISPR-Cas9 system in applications such as genome regulation and epigenome engineering, as well as the challenges faced.

Entities:  

Keywords:  CRISPR–Cas9; genome editing; édition du génome

Mesh:

Substances:

Year:  2016        PMID: 28103055     DOI: 10.1139/bcb-2016-0159

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  4 in total

1.  CRISPR-mediated Genome Editing of the Human Fungal Pathogen Candida albicans.

Authors:  Ben A Evans; Ethan S Pickerill; Valmik K Vyas; Douglas A Bernstein
Journal:  J Vis Exp       Date:  2018-11-14       Impact factor: 1.355

2.  The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature.

Authors:  Nienke de Graeff; Karin R Jongsma; Josephine Johnston; Sarah Hartley; Annelien L Bredenoord
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-13       Impact factor: 6.237

Review 3.  Gene Editing in Clinical Practice: Where are We?

Authors:  Rama Devi Mittal
Journal:  Indian J Clin Biochem       Date:  2019-01-01

Review 4.  CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment.

Authors:  Itishree Kaushik; Sharavan Ramachandran; Sanjay K Srivastava
Journal:  Semin Cell Dev Biol       Date:  2019-05-04       Impact factor: 7.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.